A NON-PROFIT ORGANIZATION TO BUILD AWARENESS ABOUT HPV THROAT CANCER
- Education 20 million Americans are currently infected with HPV. Learn about HPV infection and who is at risk of getting HPV throat cancer.
- Prevention The CDC recommends the HPV vaccine for females age 11-26 and males age 11 to 21.
- Support Find about clinical trials for HPV throat cancer patients.
- Support Learn how to enjoy eating again after treatment and how to live your best new normal.
- Get Involved Share your story, read about others' experiences. Together, we can help and learn from each other.
The American Society of Clinical Oncologists says by 2020, the number of cases of HPV-related oropharyngeal cancers in middle-age, non-smoking men will surpass that of cervical cancer. Women can also get it.
The best prevention is vaccination AND to learn about the early symptoms of HPV-positive throat cancer: lump in the throat, difficulty swallowing, hoarseness or unusually persistent sore throat. See your doctor and if the symptoms persist, see a Head and Neck specialist without delay. Doctors say with early detection, the prognosis for HPV-related throat cancer in non-smoking patients is at least 90%.
Dr. Robert Jacobson, professor of pediatrics, Mayo Clinic, on what parents and adolescents need to know about the HPV vaccine. More about the HPV vaccine for young adults.
Our gratitude to HPV throat cancer patients for sharing their personal stories to help others. How to share your story.
Dr. Sara Pai gives candid answers in our series of informative videos. Dr. Pai is a lead researcher of HPV oropharyngeal cancer at Harvard Medical School and practices otolaryngology at Massachusetts General Hospital. She is a former associate professor at Johns Hopkins School of Medicine, Dept. of Otolaryngology – Head and Neck Surgery.
If you’ve been diagnosed with HPV-positive head or neck cancer, you may be eligible. This Mayo Clinic trial seeks to reduce the long-term side effects from radiation such as dry mouth, difficulty swallowing, and altered taste.
National Institutes of Health awards grant to study whether proactive communication tools can increase HPV vaccination rates.
National Cancer Institute reports results of three head and neck cancer trials.
New research in the Journal of Cancer Policy outlines the need for an “oncopolicy” among high-income countries to find “actionable strategies that policy-makers could implement to reduce the number of people diagnosed with the disease, enhance the quality of life for those living with the disease and lessen the likelihood of dying from the disease.”